Impact of Next-Generation DNA Sequencing in GI Malignancies: KRAS Amplification and Anti-EGFR Therapy Resistant Mutations by Next-Generation. Sequencing in a Survey of GI Malignancies

Brinkerhoff B.; Grasso C.; Neff T.; Quist M.; Beadling C.; Corless C.

首页> 外文期刊>The Journal of molecular diagnostics: JMD >Impact of Next-Generation DNA Sequencing in GI Malignancies: KRAS Amplification and Anti-EGFR Therapy Resistant Mutations by Next-Generation. Sequencing in a Survey of GI Malignancies

【24h】

Impact of Next-Generation DNA Sequencing in GI Malignancies: KRAS Amplification and Anti-EGFR Therapy Resistant Mutations by Next-Generation. Sequencing in a Survey of GI Malignancies

机译：胃肠道恶性肿瘤中下一代DNA测序的影响：下一代的KRAS扩增和抗EGFR治疗耐药性突变。胃肠道恶性肿瘤调查中的测序

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of molecular diagnostics: JMD 》 |2014年第6期| 共1页
作者
Brinkerhoff B.; Grasso C.; Neff T.; Quist M.; Beadling C.; Corless C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类临床医学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Next-Generation DNA Sequencing in GI Malignancies: KRAS Amplification and Anti-EGFR Therapy Resistant Mutations by Next-Generation. Sequencing in a Survey of GI Malignancies [J] . Brinkerhoff B., Grasso C., Neff T., The Journal of molecular diagnostics: JMD . 2014 ,第6期

机译：胃肠道恶性肿瘤中下一代DNA测序的影响：下一代的KRAS扩增和抗EGFR治疗耐药性突变。胃肠道恶性肿瘤调查中的测序
2. Determination of IDH1 Mutational Burden and Clearance Via Next-Generation Sequencing in Patients with IDH1 Mutation-Positive Hematologic Malignancies Receiving AG-120, a First-in-Class Inhibitor of Mutant IDH1 [J] . DiNardo Courtney D., de Botton Stephane, Stein Eytan M., Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：IDH1突变阳性血液系统恶性肿瘤接受AG-120（突变IDH1的第一个抑制剂）的患者通过下一代测序确定IDH1突变的负担和清除率
3. Rational "Error Elimination" Approach to Evaluating Molecular Barcoded Next-Generation Sequencing Data Identifies Low-Frequency Mutations in Hematologic Malignancies [J] . Mallampati Saradhi, Duose Dzifa Y., Harmon Michael A., The Journal of molecular diagnostics: JMD . 2019 ,第3期

机译：评估分子条形码下一代测序数据的Rational“错误消除”方法识别血液学恶性肿瘤中的低频突变
4. Microfluidic PCR Amplification for Next-Generation Sequencing of GAA to Detect Mutations that Cause Pompe Disease [C] . Patricia W. Mueller, Gregory R. Kerr, Justine I. Lyons, International Sample Prep Technologies Conference . 2015

机译：Gaa的下一代测序的微流体PCR扩增以检测引起群众疾病的突变
5. Computational Methodologies for Transcript Analysis in the Age of Next-Generation DNA Sequencing. [D] . Habegger, Lukas. 2012

机译：下一代DNA测序时代的转录本分析的计算方法。
6. Rational Error Elimination Approach to Evaluating Molecular Barcoded Next-Generation Sequencing Data Identifies Low-Frequency Mutations in Hematologic Malignancies [O] . Saradhi Mallampati, Dzifa Y. Duose, Michael A. Harmon, 2019

机译：评估分子条形码下一代测序数据的理性消除错误方法可确定血液系统恶性肿瘤的低频突变
7. Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next-Generation Sequencing–Based Hematologic Malignancy Assays With Survey Material–Specific Differences in Variant Frequencies [O] . Alissa Keegan, Julia A. Bridge, Neal I. Lindeman, 2020

机译：标准化样品的能力测试表明，具有临床下一代测序的血液学恶性病测定的高调性协议，具有调查材料的变体频率特异性差异

Impact of Next-Generation DNA Sequencing in GI Malignancies: KRAS Amplification and Anti-EGFR Therapy Resistant Mutations by Next-Generation. Sequencing in a Survey of GI Malignancies

著录项

相似文献

相关主题

期刊订阅